Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;12(4):e2533.
doi: 10.1002/brb3.2533. Epub 2022 Mar 20.

Analysis of clinical characteristics and prognostic factors in 110 patients with nitrous oxide abuse

Miao Yu  1 , Yue Qiao  1 , Weishuai Li  1 , Xiuying Fang  2 , Han Gao  1 , Dongming Zheng  1 , Ying Ma  1
Affiliations

Analysis of clinical characteristics and prognostic factors in 110 patients with nitrous oxide abuse

Miao Yu et al. Brain Behav. 2022 Apr.

Abstract

Purpose: To review the clinical symptoms, auxiliary examination findings, and outcomes of patients with nitrous oxide (N2 O) abuse, and analyze the factors that affect outcomes.

Methods: Patients with N2 O abuse treated in the Department of Neurology between January 2018 and December 2020 were included. The clinical data of these patients were collected, and follow-up was conducted to determine the outcomes.

Results: The average age of the 110 patients with N2 O abuse was 21.4 ± 4.2 years (range: 14-33 years). Clinical presentation primarily included neurological symptoms, such as limb numbness and/or weakness (97%), psychiatric symptoms, changes in appetite, and skin hyperpigmentation. Laboratory test results were characterized by vitamin B12 deficiency (60%, 34 out of 57 cases) and high homocysteine level (69%, 31 out of 45 cases). Electromyography indicated mixed axonal and demyelination injury (92%, 80 out of 87 cases). Motor and sensory nerves were simultaneously involved, and injury primarily involved the lower limbs. One hundred and seven (97%) patients were clinically diagnosed with peripheral neuropathy, of whom 26 (24%) exhibited spinal abnormalities on magnetic resonance imaging, supporting a diagnosis of subacute combined degeneration. Treatment included N2 O withdrawal and vitamin B12 supplementation. Reexamination of six patients indicated that treatment was effective. Follow-up was completed for 51 patients. Thirty-four patients (67%) recovered completely, 17 patients (33%) had residual limb numbness, and only one patient experienced relapse. Sex was an independent prognostic factor; the outcomes of female patients were better than that of male patients.

Conclusion: The recreational use of N2 O has largely expanded among youth in recent decades, which has become a growing public health concern in China. It highlights the importance of the recognition of various clinical symptoms, particularly limb numbness and/or weakness related to the cases of N2 O abuse. The therapeutic administration of vitamin B12 supplementation and N2 O withdrawal can make the overall prognosis good, especially for female patients.

Keywords: clinical characteristics; nitrous oxide; outcomes; peripheral neuropathy; vitamin B12 deficiency.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

FIGURE 1
FIGURE 1
Spinal magnetic resonance imaging. (a–d) Transverse sections of spinal cord showing “V,” inverted “V,” triangle, and elliptical signals. (e–h) Sagittal sections showing high T2 signal lesion involving the dorsal longitudinal segment of the spinal cord
FIGURE 2
FIGURE 2
Changes in vitamin B12 and homocysteine (HCY) levels in patients with nitrous oxide abuse
FIGURE 3
FIGURE 3
(a, c) Magnetic resonance image (MRI) examination of patients with nitrous oxide abuse at initial consultation showed increased T2 signal in the spinal cord at the C3–C6 level. (b, d) MRI reexamination after 1 month showed reduction of increased T2 signal in the spinal cord at the C3–C6 level
FIGURE 4
FIGURE 4
Changes in compound muscle action potential (CMAP) and motor nerve conduction velocity (MNCV) in patients with nitrous oxide abuse
See this image and copyright information in PMC

References

    1. Banks, R. G. S. , Henderson, R. J. , & Pratt, J. M. (1968) Reactions of gases in solution. Part III. Some reactions of nitrous oxide with transition‐metal complexes. Journal of the Chemical Society A: Inorganic, Physical, Theoretical, 2886–2889. 10.1039/j19680002886 - DOI
    1. Becker, D. E. , Rosenberg, M . (2008) Nitrous oxide and the inhalation anesthetics. Anesthesia Progress, 55(4), 124–131. 10.2344/0003-3006-55.4.124 - DOI - PMC - PubMed
    1. Blanco, G. , & Peters, H. A . (1983) Myeloneuropathy and macrocytosis associated with nitrous oxide abuse. Archives of Neurology, 40(7), 416–418. 10.1001/archneur.1983.04050070046009 - DOI - PubMed
    1. Brodsky, L. , & Zuniga, J . (1975) Nitrous oxide: A psychotogenic agent. Comprehensive Psychiatry, 16, 185–188. 10.1016/0010-440X(75)90065-6 - DOI - PubMed
    1. Brotman, M. , & Cullen, S. C . (1949) Supplementation with demerol during nitrous oxide anesthesia. Anesthesiology, 10, 696–705. 10.1097/00000542-194911000-00005 - DOI - PubMed

Publication types

LinkOut - more resources